Table of Content




1. Executive Summary


2. Global Dog Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Dog Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Dog Vaccine Market by Type
3.3.1: Attenuated Live Vaccines
3.3.2: Conjugate Vaccines
3.3.3: Inactivated Vaccines
3.3.4: Subunit Vaccines
3.3.5: Toxoid Vaccines
3.3.6: DNA Vaccines
3.3.7: Recombinant Vaccine


3.4: Global Dog Vaccine Market by Age
3.4.1: Below 6 months
3.4.2: Above 6 months

3.5: Global Dog Vaccine Market by End Use
3.5.1: Veterinary Hospitals & Clinics
3.5.2: Pet Owners
3.5.3: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Dog Vaccine Market by Region
4.2: North American Dog Vaccine Market

4.2.2: North American Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

4.3: European Dog Vaccine Market
4.3.1: European Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine

4.3.2: European Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

4.4: APAC Dog Vaccine Market
4.4.1: APAC Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine

4.4.2: APAC Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

4.5: ROW Dog Vaccine Market
4.5.1: ROW Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine

4.5.2: ROW Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use

6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region

6.2: Emerging Trends in the Global Dog Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Dog Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Bayer
7.2: Vetquinol
7.3: Boehringer Ingelhiem
7.4: Ceva
7.5: Eli Lilly
7.6: Heska
7.7: Merck